SKA-31
SKA-31 is a potent potassium channel activator with EC50s of 260 nM, 1.9 μM, 2.9 μM, and 2.9 μM for KCa3.1, KCa2.2, KCa2.1 and KCa2.3, respectively. SKA-31 potentiates endothelium-derived hyperpolarizing factor response and lowers blood pressure[1].
Product Specifications
CAS Number
40172-65-4
UNSPSC
12352005
Hazard Statement
H302, H319
Target
Potassium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ska-31.html
Purity
99.66
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
NC1=NC2=C3C=CC=CC3=CC=C2S1
Molecular Formula
C11H8N2S
Molecular Weight
200.27
Precautions
H302, H319
References & Citations
[1]Sankaranarayanan A, et al. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol. 2009 Feb;75 (2) :281-95.|[2]Serena Pillozzi, et al. The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome CDDP resistance in colorectal cancer cells. Br J Cancer. 2018 Jan; 118 (2) : 200–212.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-90402-100ul 100 µL
Rabbit Monoclonal Cathepsin B Antibody (010)
Sign In for Pricing
View Details 
K0056306 1.0 µg DNA
AGAP4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details GTR15086398 1 Vial
Lentiviral human CCDC6 shRNA (UAS) - Lentiviral human CCDC6 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 